U.S. Markets closed

Advanced Cell Technology names Paul Wotton as president and CEO

Advanced Cell Technology (ACTC) announced the appointment of Paul Wotton, Ph.D., to the position of President and CEO. Wotton joins ACT from Antares Pharma (ATRS), where he served as President and CEO since October, 2008.